Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes in adults
Your clinician will recommend the right option based on your weight loss goals, tolerance, and any preexisting conditions
Physicians often begin with a lower dose to check for tolerance, and the amount can be adjusted over time, but use is usually limited to two or three times a week
Over time, researchers discovered that these therapies can also support significant weight reduction
Introduction# GHK-Cu (copper peptide) and Matrixyl (palmitoyl pentapeptide-4) are two of the most widely used peptides in anti-aging skincare, both targeting collagen production and wrinkle reduction but through fundamentally different mechanisms
45 All studies that demonstrated a reduction in MACE on GLP-1RA therapy consistently involved patients with T2D